Dan Leonard
Stock Analyst at UBS
(1.58)
# 1530
Out of 5,368 analysts
287
Total ratings
52.38%
Success rate
9.50%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MTD Mettler-Toledo Intl | Upgrades: Buy | 1530 1350 | 1155.16 | 16.87% | 9 | May 20, 2025 | |
TXG 10x Genomics | Maintains: Neutral | 14 12 | 10.43 | 15.05% | 5 | May 13, 2025 | |
TECH Bio-Techne | Maintains: Buy | 95 70 | 50.53 | 38.53% | 11 | May 9, 2025 | |
BRKR Bruker | Maintains: Neutral | 57 45 | 38.3 | 17.49% | 11 | May 8, 2025 | |
IQV IQVIA Hldgs | Maintains: Buy | 255 185 | 156.81 | 17.98% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 355 310 | 227.31 | 36.38% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 65 70 | 49.26 | 42.1% | 9 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 145 115 | 93.46 | 23.05% | 2 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 715 500 | 402.51 | 24.22% | 15 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 275 240 | 200.65 | 19.61% | 14 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 29 25 | 13.07 | 91.28% | 7 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 250 185 | 149.58 | 23.68% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 7 9 | 6.68 | 34.73% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 420 350 | 298.42 | 17.28% | 1 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 16 16 | 11.02 | 45.19% | 9 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 35 | 20.68 | 69.25% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 160 150 | 117.06 | 28.14% | 20 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 225 200 | 86.96 | 129.99% | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 11 | 2.14 | 414.02% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 70 | 165.33 | -57.66% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 75 90 | 53.52 | 68.16% | 9 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Underperform | 7 | 10.31 | -32.1% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 160 | n/a | n/a | 12 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 345 | 342.12 | 0.84% | 12 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 260 | 145.74 | 78.4% | 5 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underperform | 1 | n/a | n/a | 3 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 160 145 | 180.08 | -19.48% | 10 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 95 90 | 64.75 | 39% | 12 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 62 64 | 47.08 | 35.2% | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 330 340 | 261.09 | 30.22% | 11 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 24 | 23.47 | 2.26% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 4 2 | n/a | n/a | 3 | May 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 45 35 | 5.04 | 594.44% | 11 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 80 55 | n/a | n/a | 3 | May 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Hold | 18 0 | n/a | n/a | 3 | May 7, 2018 |